Nymox Pharmaceutical Corporation

Patent Applications and Registrations

Patent applications and USPTO patent grants for Nymox Pharmaceutical Corporation.The latest application filed is for "peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells".

Company Profile

0.8.8

Nymox Pharmaceutical Corporation - St. Laurent CA
Nymox Pharmaceutical Corporation - CA CA
Nymox Pharmaceutical Corporation -
Nymox Pharmaceutical Corporation - Quebec CA
Nymox Pharmaceutical Corporation - 9900 Cavendish Boulevard Suite 306 St. Laurent CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks

Patent Activity

Patent	Date
Peptides Effective In The Treatment Of Tumors And Other Conditions Requiring The Removal Or Destruction Of Cells App 20120114679 - Averback; Paul ; et al.	2012-05-10
Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells Grant 8,067,378 - Averback , et al. November 29, 2	2011-11-29
Peptides Effective in the Treatment of Tumors and Other Conditions Requiring the Removal or Destruction of Cells App 20090286742 - AVERBACK; PAUL ; et al.	2009-11-19
Preferred segments of neural thread protein and method of using the same App 20090258426 - Fitzpatrick; Judith ; et al.	2009-10-15
Peptides Effective in the Treatment of Tumors and Other Conditions Requiring the Removal or Destruction of Cells App 20090022743 - Averback; Paul ; et al.	2009-01-22
Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells Grant 7,408,021 - Averback , et al. August 5, 2	2008-08-05
Humanized Antibody App 20080063598 - Averback; Paul ; et al.	2008-03-13
Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells Grant 7,317,077 - Averback , et al. January 8, 2	2008-01-08
Preferred segments of neural thread protein Grant 7,259,232 - Fitzpatrick , et al. August 21, 2	2007-08-21
Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells Grant 7,241,738 - Averback , et al. July 10, 2	2007-07-10
Isolated components of dense microspheres derived from mammalian brain tissue and antibodies thereto App 20050191711 - Averback, Paul	2005-09-01
Peptides effective in the treatment of tumors and other conditions requiring the removal ordestruction of cells App 20050032704 - Averback, Paul ; et al.	2005-02-10
Methods of using neural thread proteins to treat tumors and other conditions requiring the removal or destruction of cells App 20030054990 - Averback, Paul	2003-03-20
Bacteriophage composition useful in treating food products to prevent bacterial contamination Grant 6,461,608 - Averback , et al. October 8, 2	2002-10-08
Antibodies to components of dense microspheres and methods of using the same Grant 6,309,892 - Averback October 30, 2	2001-10-30
Method of identifying individuals at risk of suffering from cerebral amyloidosis Grant 5,955,285 - Averback September 21, 1	1999-09-21

Company Registrations

SEC

0001018735

NYMOX PHARMACEUTICAL CORP

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.